Literature DB >> 26191219

Ca2+-calcineurin signaling is involved in norepinephrine-induced cardiac fibroblasts activation.

Chun-Jing Tian1, Xiao Pang1.   

Abstract

Cardiac fibroblasts (CFs) activation plays a vital role in cardiac fibrosis. There are some studies demonstrate that norepinephrine (NE, an α1-adrenoceptor agonist) induced CFs proliferation. But whether Ca2+-calcineurin, a signaling concerned with growth and differentiation in various cell types, is participated in NE-induced CFs activation is unclear. In present study, we determined NE-induced CFs proliferation and differentiation, synthesis of collagen, and calcineurin (CaN) activity, and the effects of phentolamine (Phen, an α1-adrenoceptor antagonist), verapamil (Ver, a calcium channel blocker) and cyclosporine A (CsA, an inhibitor of CaN) on NE-induced CFs activation. The results showed that NE induced CFs proliferation and differentiation, increased α-SMA protein expression, increased collagen I, collagen III and fibronectin production, promoted ECM expression, activated CaN and increased CaN protein expression, which were inhibited by Phen, Ver and CsA. In vivo, more collagen deposition could be observed and total collagen volume fraction (CVF) was significantly increased in NE group. Phen, Ver and CsA decreased NE-induced collagen deposition, reduced cardiac fibrosis. Thus, our results demonstrate that Ca2+/CaN is involved in NE-induced CFs proliferation and collagen synthesis.

Entities:  

Keywords:  Calcineurin; activation; cardiac fibroblasts; norepinephrine

Mesh:

Substances:

Year:  2015        PMID: 26191219      PMCID: PMC4503091     

Source DB:  PubMed          Journal:  Int J Clin Exp Pathol        ISSN: 1936-2625


  20 in total

Review 1.  Inhibition of the calcineurin-NFAT signalling cascade in the treatment of heart failure.

Authors:  Franziska Panther; Tatjana Williams; Oliver Ritter
Journal:  Recent Pat Cardiovasc Drug Discov       Date:  2009-11

2.  Angiotensin II signalling and calcineurin in cardiac fibroblasts: differential effects of calcineurin inhibitors FK506 and cyclosporine A.

Authors:  Michel White; Augusto C Montezano; Rhian M Touyz
Journal:  Ther Adv Cardiovasc Dis       Date:  2011-12-19

Review 3.  An "I" on cardiac hypertrophic remodelling: imidazoline receptors and heart disease.

Authors:  Suhayla Mukaddam-Daher
Journal:  Can J Cardiol       Date:  2012-04-06       Impact factor: 5.223

4.  Effects of arginine vasopressin on differentiation of cardiac fibroblasts into myofibroblasts.

Authors:  Fan Yan-Hong; Dong Hui; Pan Qing; Shang Lei; Wang Hai-Chang; Zhang Wei; Cao Yan-Jie
Journal:  J Cardiovasc Pharmacol       Date:  2010-05       Impact factor: 3.105

Review 5.  The origin of fibroblasts and mechanism of cardiac fibrosis.

Authors:  Guido Krenning; Elisabeth M Zeisberg; Raghu Kalluri
Journal:  J Cell Physiol       Date:  2010-11       Impact factor: 6.384

Review 6.  Sympathetic nervous system activation in human heart failure: clinical implications of an updated model.

Authors:  John S Floras
Journal:  J Am Coll Cardiol       Date:  2009-07-28       Impact factor: 24.094

7.  Electrical field stimulation induces cardiac fibroblast proliferation through the calcineurin-NFAT pathway.

Authors:  Qing-Qing Chen; Wei Zhang; Xiang-Fan Chen; Yun-Jian Bao; Jing Wang; Wei-Zhong Zhu
Journal:  Can J Physiol Pharmacol       Date:  2012-11-26       Impact factor: 2.273

8.  Matrix metalloproteinase-2 stimulates collagen-I expression through phosphorylation of focal adhesion kinase in rat cardiac fibroblasts.

Authors:  Yasutomo Hori; Takashige Kashimoto; Tomohiro Yonezawa; Naoya Sano; Ryuta Saitoh; Shinya Igarashi; Seishiro Chikazawa; Kazutaka Kanai; Fumio Hoshi; Naoyuki Itoh; Sei-Ichi Higuchi
Journal:  Am J Physiol Cell Physiol       Date:  2012-08-22       Impact factor: 4.249

9.  Syndecan-4 signaling via NFAT regulates extracellular matrix production and cardiac myofibroblast differentiation in response to mechanical stress.

Authors:  Kate M Herum; Ida G Lunde; Biljana Skrbic; Geir Florholmen; Dina Behmen; Ivar Sjaastad; Cathrine R Carlson; Maria F Gomez; Geir Christensen
Journal:  J Mol Cell Cardiol       Date:  2012-11-22       Impact factor: 5.000

10.  Prokineticin 1 modulates IL-8 expression via the calcineurin/NFAT signaling pathway.

Authors:  David Maldonado-Pérez; Pamela Brown; Kevin Morgan; Robert P Millar; E Aubrey Thompson; Henry N Jabbour
Journal:  Biochim Biophys Acta       Date:  2009-04-05
View more
  3 in total

1.  Exchange protein activated by cyclic-adenosine monophosphate (Epac) regulates atrial fibroblast function and controls cardiac remodelling.

Authors:  Sirirat Surinkaew; Mona Aflaki; Abhijit Takawale; Yu Chen; Xiao-Yan Qi; Marc-Antoine Gillis; Yan-Fen Shi; Jean-Claude Tardif; Nipon Chattipakorn; Stanley Nattel
Journal:  Cardiovasc Res       Date:  2019-01-01       Impact factor: 10.787

2.  Fibroblast Growth Factor 23 Stimulates Cardiac Fibroblast Activity through Phospholipase C-Mediated Calcium Signaling.

Authors:  Ting-Wei Lee; Cheng-Chih Chung; Ting-I Lee; Yung-Kuo Lin; Yu-Hsun Kao; Yi-Jen Chen
Journal:  Int J Mol Sci       Date:  2021-12-23       Impact factor: 5.923

3.  A Catecholaldehyde Metabolite of Norepinephrine Induces Myofibroblast Activation and Toxicity via the Receptor for Advanced Glycation Endproducts: Mitigating Role of l-Carnosine.

Authors:  T Blake Monroe; Ethan J Anderson
Journal:  Chem Res Toxicol       Date:  2021-10-05       Impact factor: 3.739

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.